APA

Quan C., Xiao J., Duan Q., Yuan P., Xue P., Lu H., Yan M., Guo D., Xu S., Zhang X., Lin X., Wang Y., Dogan S., Zhang J., Zhu F., Ke C. & Liu L. (2018). T-lymphokine-activated killer cell-originated protein kinase (TOPK) as a prognostic factor and a potential therapeutic target in glioma. : Oncotarget.

Chicago

Quan Chuntao, Xiao Juanjuan, Duan Qiuhong, Yuan Ping, Xue Peipei, Lu Hui, Yan Meng, Guo Dongsheng, Xu Sanpeng, Zhang Xiaohui, Lin Xuan, Wang Yong, Dogan Soner, Zhang Jianmin, Zhu Feng, Ke Changshu and Liu Lin. 2018. T-lymphokine-activated killer cell-originated protein kinase (TOPK) as a prognostic factor and a potential therapeutic target in glioma. : Oncotarget.

Harvard

Quan C., Xiao J., Duan Q., Yuan P., Xue P., Lu H., Yan M., Guo D., Xu S., Zhang X., Lin X., Wang Y., Dogan S., Zhang J., Zhu F., Ke C. and Liu L. (2018). T-lymphokine-activated killer cell-originated protein kinase (TOPK) as a prognostic factor and a potential therapeutic target in glioma. : Oncotarget.

MLA

Quan Chuntao, Xiao Juanjuan, Duan Qiuhong, Yuan Ping, Xue Peipei, Lu Hui, Yan Meng, Guo Dongsheng, Xu Sanpeng, Zhang Xiaohui, Lin Xuan, Wang Yong, Dogan Soner, Zhang Jianmin, Zhu Feng, Ke Changshu and Liu Lin. T-lymphokine-activated killer cell-originated protein kinase (TOPK) as a prognostic factor and a potential therapeutic target in glioma. : Oncotarget. 2018.